238 related articles for article (PubMed ID: 22474281)
1. Fenretinide prevents lipid-induced insulin resistance by blocking ceramide biosynthesis.
Bikman BT; Guan Y; Shui G; Siddique MM; Holland WL; Kim JY; Fabriàs G; Wenk MR; Summers SA
J Biol Chem; 2012 May; 287(21):17426-17437. PubMed ID: 22474281
[TBL] [Abstract][Full Text] [Related]
2. Fenretinide inhibits obesity and fatty liver disease but induces Smpd3 to increase serum ceramides and worsen atherosclerosis in LDLR
Thompson D; Mahmood S; Morrice N; Kamli-Salino S; Dekeryte R; Hoffmann PA; Doherty MK; Whitfield PD; Delibegović M; Mody N
Sci Rep; 2023 Mar; 13(1):3937. PubMed ID: 36894641
[TBL] [Abstract][Full Text] [Related]
3. Sulforaphane Prevents Hepatic Insulin Resistance by Blocking Serine Palmitoyltransferase 3-Mediated Ceramide Biosynthesis.
Teng W; Li Y; Du M; Lei X; Xie S; Ren F
Nutrients; 2019 May; 11(5):. PubMed ID: 31137828
[TBL] [Abstract][Full Text] [Related]
4. Fenretinide ameliorates insulin resistance and fatty liver in obese mice.
Koh IU; Jun HS; Choi JS; Lim JH; Kim WH; Yoon JB; Song J
Biol Pharm Bull; 2012; 35(3):369-75. PubMed ID: 22382323
[TBL] [Abstract][Full Text] [Related]
5. Fenretinide inhibited de novo ceramide synthesis and proinflammatory cytokines induced by Aggregatibacter actinomycetemcomitans.
Yu H; Valerio M; Bielawski J
J Lipid Res; 2013 Jan; 54(1):189-201. PubMed ID: 23139430
[TBL] [Abstract][Full Text] [Related]
6. Characterizing the effects of saturated fatty acids on insulin signaling and ceramide and diacylglycerol accumulation in 3T3-L1 adipocytes and C2C12 myotubes.
Chavez JA; Summers SA
Arch Biochem Biophys; 2003 Nov; 419(2):101-9. PubMed ID: 14592453
[TBL] [Abstract][Full Text] [Related]
7. The mechanisms of Fenretinide-mediated anti-cancer activity and prevention of obesity and type-2 diabetes.
Mody N; Mcilroy GD
Biochem Pharmacol; 2014 Oct; 91(3):277-86. PubMed ID: 25069047
[TBL] [Abstract][Full Text] [Related]
8. The sphingosine-1-phosphate analog FTY720 reduces muscle ceramide content and improves glucose tolerance in high fat-fed male mice.
Bruce CR; Risis S; Babb JR; Yang C; Lee-Young RS; Henstridge DC; Febbraio MA
Endocrinology; 2013 Jan; 154(1):65-76. PubMed ID: 23183172
[TBL] [Abstract][Full Text] [Related]
9. Fenretinide corrects newly found ceramide deficiency in cystic fibrosis.
Guilbault C; De Sanctis JB; Wojewodka G; Saeed Z; Lachance C; Skinner TA; Vilela RM; Kubow S; Lands LC; Hajduch M; Matouk E; Radzioch D
Am J Respir Cell Mol Biol; 2008 Jan; 38(1):47-56. PubMed ID: 17656682
[TBL] [Abstract][Full Text] [Related]
10. Saturated- and n-6 polyunsaturated-fat diets each induce ceramide accumulation in mouse skeletal muscle: reversal and improvement of glucose tolerance by lipid metabolism inhibitors.
Frangioudakis G; Garrard J; Raddatz K; Nadler JL; Mitchell TW; Schmitz-Peiffer C
Endocrinology; 2010 Sep; 151(9):4187-96. PubMed ID: 20660065
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory effects of fenretinide metabolites N-[4-methoxyphenyl]retinamide (MPR) and 4-oxo-N-(4-hydroxyphenyl)retinamide (3-keto-HPR) on fenretinide molecular targets β-carotene oxygenase 1, stearoyl-CoA desaturase 1 and dihydroceramide Δ4-desaturase 1.
Poliakov E; Samuel W; Duncan T; Gutierrez DB; Mata NL; Redmond TM
PLoS One; 2017; 12(4):e0176487. PubMed ID: 28448568
[TBL] [Abstract][Full Text] [Related]
12. Sustained Action of Ceramide on the Insulin Signaling Pathway in Muscle Cells: IMPLICATION OF THE DOUBLE-STRANDED RNA-ACTIVATED PROTEIN KINASE.
Hage Hassan R; Pacheco de Sousa AC; Mahfouz R; Hainault I; Blachnio-Zabielska A; Bourron O; Koskas F; Górski J; Ferré P; Foufelle F; Hajduch E
J Biol Chem; 2016 Feb; 291(6):3019-29. PubMed ID: 26698173
[TBL] [Abstract][Full Text] [Related]
13. Low molecular weight fucoidan improves endoplasmic reticulum stress-reduced insulin sensitivity through AMP-activated protein kinase activation in L6 myotubes and restores lipid homeostasis in a mouse model of type 2 diabetes.
Jeong YT; Kim YD; Jung YM; Park DC; Lee DS; Ku SK; Li X; Lu Y; Chao GH; Kim KJ; Lee JY; Baek MC; Kang W; Hwang SL; Chang HW
Mol Pharmacol; 2013 Jul; 84(1):147-57. PubMed ID: 23658008
[TBL] [Abstract][Full Text] [Related]
14. Saturated, but not n-6 polyunsaturated, fatty acids induce insulin resistance: role of intramuscular accumulation of lipid metabolites.
Lee JS; Pinnamaneni SK; Eo SJ; Cho IH; Pyo JH; Kim CK; Sinclair AJ; Febbraio MA; Watt MJ
J Appl Physiol (1985); 2006 May; 100(5):1467-74. PubMed ID: 16357064
[TBL] [Abstract][Full Text] [Related]
15. Ceramide generation is sufficient to account for the inhibition of the insulin-stimulated PKB pathway in C2C12 skeletal muscle cells pretreated with palmitate.
Schmitz-Peiffer C; Craig DL; Biden TJ
J Biol Chem; 1999 Aug; 274(34):24202-10. PubMed ID: 10446195
[TBL] [Abstract][Full Text] [Related]
16. Ceramide mediates vascular dysfunction in diet-induced obesity by PP2A-mediated dephosphorylation of the eNOS-Akt complex.
Zhang QJ; Holland WL; Wilson L; Tanner JM; Kearns D; Cahoon JM; Pettey D; Losee J; Duncan B; Gale D; Kowalski CA; Deeter N; Nichols A; Deesing M; Arrant C; Ruan T; Boehme C; McCamey DR; Rou J; Ambal K; Narra KK; Summers SA; Abel ED; Symons JD
Diabetes; 2012 Jul; 61(7):1848-59. PubMed ID: 22586587
[TBL] [Abstract][Full Text] [Related]
17. Ceramides contained in LDL are elevated in type 2 diabetes and promote inflammation and skeletal muscle insulin resistance.
Boon J; Hoy AJ; Stark R; Brown RD; Meex RC; Henstridge DC; Schenk S; Meikle PJ; Horowitz JF; Kingwell BA; Bruce CR; Watt MJ
Diabetes; 2013 Feb; 62(2):401-10. PubMed ID: 23139352
[TBL] [Abstract][Full Text] [Related]
18. Long-term Fenretinide treatment prevents high-fat diet-induced obesity, insulin resistance, and hepatic steatosis.
Preitner F; Mody N; Graham TE; Peroni OD; Kahn BB
Am J Physiol Endocrinol Metab; 2009 Dec; 297(6):E1420-9. PubMed ID: 19826103
[TBL] [Abstract][Full Text] [Related]
19. Gangliosides link the acidic sphingomyelinase-mediated induction of ceramide to 12-lipoxygenase-dependent apoptosis of neuroblastoma in response to fenretinide.
Lovat PE; Di Sano F; Corazzari M; Fazi B; Donnorso RP; Pearson AD; Hall AG; Redfern CP; Piacentini M
J Natl Cancer Inst; 2004 Sep; 96(17):1288-99. PubMed ID: 15339967
[TBL] [Abstract][Full Text] [Related]
20. Regulation of G1/S transition and induction of apoptosis in HL-60 leukemia cells by fenretinide (4HPR).
DiPietrantonio AM; Hsieh TC; Olson SC; Wu JM
Int J Cancer; 1998 Sep; 78(1):53-61. PubMed ID: 9724094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
